Enzyme Replacement Therapy for the Management of the Mucopolysaccharidoses
Overview
Authors
Affiliations
Enzyme replacement therapy (ERT) is now available for several of the mucopolysaccharidosis disorders. This brief review summarizes the role of ERT in reducing the burden of peripheral disease in many patients with mucopolysaccharidosis disorders, and describes the challenges that remain in treating the neurological manifestations of these conditions.
Colon C, Alvarez J, Castano C, Gutierrez-Solana L, Marquez A, OCallaghan M Medicine (Baltimore). 2017; 96(19):e6887.
PMID: 28489793 PMC: 5428627. DOI: 10.1097/MD.0000000000006887.
Tkachyova I, Fan X, Lamhonwah A, Fedyshyn B, Tein I, Mahuran D PLoS One. 2016; 11(9):e0162145.
PMID: 27657498 PMC: 5033324. DOI: 10.1371/journal.pone.0162145.
Brands M, Gungor D, van den Hout J, Karstens F, Oussoren E, Plug I J Inherit Metab Dis. 2014; 38(2):323-31.
PMID: 25048386 DOI: 10.1007/s10545-014-9737-0.
Newborn screening and diagnosis of mucopolysaccharidoses.
Tomatsu S, Fujii T, Fukushi M, Oguma T, Shimada T, Maeda M Mol Genet Metab. 2013; 110(1-2):42-53.
PMID: 23860310 PMC: 4047214. DOI: 10.1016/j.ymgme.2013.06.007.
Volpi N, Zampini L, Maccari F, Santoro L, Galeotti F, Galeazzi T Glycoconj J. 2013; 30(7):727-32.
PMID: 23512580 DOI: 10.1007/s10719-013-9471-0.